German MEP, rapporteur for the pharmaceutical regulation
Appears in 1 story
Key Parliament architect of the final compromise on incentives and access
After two years of trench warfare between EU governments, lawmakers and drug makers, Brussels has finally agreed a ‘pharma package’ that tears up the bloc’s 20‑year‑old drug rules. The deal locks in eight years of data protection and one year of market exclusivity for new medicines, with bonuses that can stretch protection to 11 years if companies hit public‑health goals.
Updated Jan 9
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
